TREATMENT ADHERENCE TO CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Feldman, C. H. [1 ]
Lii, J. [1 ]
Gopalakrishnan, C. [1 ]
Franklin, J. M. [1 ]
Kim, S. C. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5544
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0664
引用
收藏
页码：526 / 526
页数：1
相关论文
共 50 条
  • [41] German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
    Katinka Albrecht
    Klaus Krüger
    Jürgen Wollenhaupt
    Rieke Alten
    Marina Backhaus
    Christoph Baerwald
    Wolfgang Bolten
    Jürgen Braun
    Harald Burkhardt
    Gerd R. Burmester
    Markus Gaubitz
    Angela Gause
    Erika Gromnica-Ihle
    Herbert Kellner
    Jens Kuipers
    Andreas Krause
    Hans-Martin Lorenz
    Bernhard Manger
    Hubert Nüßlein
    Hans-Georg Pott
    Andrea Rubbert-Roth
    Matthias Schneider
    Christof Specker
    Hendrik Schulze-Koops
    Hans-Peter Tony
    Siegfried Wassenberg
    Ulf Müller-Ladner
    Rheumatology International, 2014, 34 : 1 - 9
  • [42] Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
    Jin, Yinzhu
    Desai, Rishi J.
    Liu, Jun
    Choi, Nam-Kyong
    Kim, Seoyoung C.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [43] German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
    Albrecht, Katinka t
    Krueger, Klaus
    Wollenhaupt, Juergen
    Alten, Rieke
    Backhaus, Marina
    Baerwald, Christoph
    Bolten, Wolfgang
    Braun, Juergen
    Burkhardt, Harald
    Burmester, Gerd R.
    Gaubitz, Markus
    Gause, Angela
    Gromnica-Ihle, Erika
    Kellner, Herbert
    Kuipers, Jens
    Krause, Andreas
    Lorenz, Hans-Martin
    Manger, Bernhard
    Nuesslein, Hubert
    Pott, Hans-Georg
    Rubbert-Roth, Andrea
    Schneider, Matthias
    Specker, Christof
    Schulze-Koops, Hendrik
    Tony, Hans-Peter
    Wassenberg, Siegfried
    Mueller-Ladner, Ulf
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) : 1 - 9
  • [44] Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
    Diaz-Borjon, Alejandro
    DRUGS & AGING, 2009, 26 (04) : 273 - 293
  • [45] Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
    Alejandro Díaz-Borjón
    Drugs & Aging, 2009, 26 : 273 - 293
  • [46] Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control
    Lillegraven, Siri
    Sundlisaeter, Nina Paulshus
    Aga, Anna-Birgitte
    Sexton, Joseph
    Solomon, Daniel H.
    van der Heijde, Desiree
    Haavardsholm, Espen A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12): : 1024 - 1026
  • [47] Prevalence of Anemia Among Rheumatoid Arthritis Patients Treated with Conventional Disease-Modifying Antirheumatic Drugs
    Kay, Jonathan
    Rancourt, Joshua
    Bradley, John D.
    Arora, Vipin K.
    Zhong, Jinglin
    Dickson, Christina
    Muram, David
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis
    Feely, Michael G.
    O'Dell, James R.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 316 - 320
  • [49] Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis
    Betts, Keith A.
    Griffith, Jenny
    Ganguli, Arijit
    Li, Nanxin
    Douglas, Kevin
    Wu, Eric Q.
    CLINICAL THERAPEUTICS, 2016, 38 (05) : 1205 - 1216
  • [50] Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy
    Convertino, Irma
    Giometto, Sabrina
    Gini, Rosa
    Cazzato, Massimiliano
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Fornili, Marco
    Turchetti, Giuseppe
    Lorenzoni, Valentina
    Trieste, Leopoldo
    Mosca, Marta
    Blandizzi, Corrado
    Tuccori, Marco
    Lucenteforte, Ersilia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 246 - 246
12345